Successful Percutaneous Transcatheter Aortic Valve Replacement for Severe Aortic Regurgitation in a High-risk Patient with Cardiorenal Syndrome.

Autor: Mutlu D; Department of Cardiology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa Istanbul, Turkey.; Center for Coronary ArteryDisease, Minneapolis Heart Institute Foundation Minneapolis, MN., Inanc IH; Department of Cardiology, Kirikkale Yuksek Ihtisas Hospital Kirikkale, Turkey., Mutlu OPZ; Department of Cardiology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa Istanbul, Turkey., Marmagkiolis K; Department of Cardiology, MD Anderson Cancer Center, University of Texas Houston, TX.; Department of Cardiology, Tampa General Hospital, University of South Florida Tampa, FL., Iliescu CA; Department of Cardiology, MD Anderson Cancer Center, University of Texas Houston, TX., Cilingiroglu M; Department of Cardiology, MD Anderson Cancer Center, University of Texas Houston, TX.; Department of Cardiology, University of Texas Health Science Center at San Antonio San Antonio, TX.
Jazyk: angličtina
Zdroj: US cardiology [US Cardiol] 2024 Nov 13; Vol. 18, pp. e20. Date of Electronic Publication: 2024 Nov 13 (Print Publication: 2024).
DOI: 10.15420/usc.2024.19
Abstrakt: The absence of a Food and Drug Administration-approved percutaneous valve technology for the treatment of severe aortic regurgitation (AR) presents a challenge for high-risk patients. In this report, we describe the successful treatment of an 84-year-old male patient suffering from severe symptomatic AR and concomitant cardiorenal syndrome with renal failure using a 34 mm Evolut R (Medtronic) self-expanding transcatheter aortic valve replacement. This intervention resulted in the resolution of AR, cardiorenal syndrome, and congestive heart failure symptoms.
Competing Interests: Disclosure: All authors have no conflicts of interest to declare. Consent: Written informed consent was obtained from the patient for the publication of the case report and the accompanying images.
(Copyright © The Author(s), 2024. Published by Radcliffe Group Ltd.)
Databáze: MEDLINE